148 related articles for article (PubMed ID: 2849901)
1. In vitro blockade of neuromuscular transmission by monoclonal anti-acetylcholine receptor antibodies.
Maselli RA; Jow B; Richman DP; Nelson DJ
Ann N Y Acad Sci; 1988; 540():523-4. PubMed ID: 2849901
[No Abstract] [Full Text] [Related]
2. Chronic experimental autoimmune myasthenia gravis induced by monoclonal antibody to acetylcholine receptor: biochemical and electrophysiologic criteria.
Gomez CM; Richman DP
J Immunol; 1987 Jul; 139(1):73-6. PubMed ID: 3035025
[TBL] [Abstract][Full Text] [Related]
3. Immunisation with Torpedo acetylcholine receptor.
Elfman L
Prog Neurobiol; 1984; 23(1-2):39-62. PubMed ID: 6097937
[TBL] [Abstract][Full Text] [Related]
4. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation.
de Crousaz G; Fulpius BW
Lancet; 1978 Jan; 1(8054):47. PubMed ID: 74528
[No Abstract] [Full Text] [Related]
5. Seronegative myasthenia gravis. Evidence for plasma factor(s) interfering with acetylcholine receptor function.
Vincent A; Li Z; Hart A; Barrett-Jolley R; Yamamoto T; Burges J; Wray D; Byrne N; Molenaar P; Newsom-Davis J
Ann N Y Acad Sci; 1993 Jun; 681():529-38. PubMed ID: 8395163
[No Abstract] [Full Text] [Related]
6. Effects of drugs and antibodies on the post-synaptic membrane of the neuromuscular junction.
Peper K; Sterz R; Bradley RJ
Ann N Y Acad Sci; 1981; 377():519-43. PubMed ID: 6978665
[No Abstract] [Full Text] [Related]
7. Immunological heterogeneity and cellular mechanisms in myasthenia gravis.
Newsom-Davis J; Willcox N; Schluep M; Harcourt G; Vincent A; Mossman S; Wray D; Burges J
Ann N Y Acad Sci; 1987; 505():12-26. PubMed ID: 2825574
[No Abstract] [Full Text] [Related]
8. The neuromuscular junction: recent developments.
Bowman WC
Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
[No Abstract] [Full Text] [Related]
9. Myasthenia gravis and autoimmunity.
Whitaker JN
Adv Intern Med; 1980; 26():489-510. PubMed ID: 6164271
[No Abstract] [Full Text] [Related]
10. Humoral pathogenesis of myasthenia gravis.
Drachman DB; de Silva S; Ramsay D; Pestronk A
Ann N Y Acad Sci; 1987; 505():90-105. PubMed ID: 2446560
[No Abstract] [Full Text] [Related]
11. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
Mossman S; Vincent A; Newsom-Davis J
Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
[TBL] [Abstract][Full Text] [Related]
12. The role of acetylcholine receptor antibodies in myasthenia gravis.
Appel SH; Elias SB; Chauvin P
Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
[TBL] [Abstract][Full Text] [Related]
13. Effects of myasthenic immunoglobulins and of prednisolone on spontaneous miniature end-plate potentials in mouse diaphragms.
Dudel J; Birnberger KL; Toyka KV; Schlegel C; Besinger U
Exp Neurol; 1979 Nov; 66(2):365-80. PubMed ID: 226390
[No Abstract] [Full Text] [Related]
14. Autoimmune Attack of the Neuromuscular Junction in Myasthenia Gravis: Nicotinic Acetylcholine Receptors and Other Targets.
Paz ML; Barrantes FJ
ACS Chem Neurosci; 2019 May; 10(5):2186-2194. PubMed ID: 30916550
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of myasthenia gravis.
Hughes BW; Moro De Casillas ML; Kaminski HJ
Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
[TBL] [Abstract][Full Text] [Related]
16. Functional inhibition of acetylcholine receptors by antibodies in myasthenic sera.
Hall ZW; Pizzighella S; Gu Y; Vicini S; Schuetze SM
Ann N Y Acad Sci; 1987; 505():272-85. PubMed ID: 2446552
[No Abstract] [Full Text] [Related]
17. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
Lindstrom J
Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
[No Abstract] [Full Text] [Related]
18. Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.
Toyka KV; Löwenadler B; Heininger K; Besinger UA; Birnberger KL; Fateh-Moghadam A; Heilbronn E
J Neurol Neurosurg Psychiatry; 1980 Sep; 43(9):836-42. PubMed ID: 6252294
[TBL] [Abstract][Full Text] [Related]
19. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
[TBL] [Abstract][Full Text] [Related]
20. Effects of a monoclonal anti-acetylcholine receptor antibody on the avian end-plate.
Maselli RA; Nelson DJ; Richman DP
J Physiol; 1989 Apr; 411():271-83. PubMed ID: 2614725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
